| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/16/2002 | WO2002038789A1 Methods for preparation of a nucleic acid for analysis |
| 05/16/2002 | WO2002038778A1 Differentiation-inducing substances |
| 05/16/2002 | WO2002038773A2 A human phospholipase c and uses thereof |
| 05/16/2002 | WO2002038771A1 Drug-tolerant hiv integrases |
| 05/16/2002 | WO2002038762A1 Method of acquiring gene specific to nerve formation of vertebrate |
| 05/16/2002 | WO2002038757A1 Method for generating recombinant dna library using unidirectional single-stranded dna fragments |
| 05/16/2002 | WO2002038755A1 Circular extra-chromosomal dna elements |
| 05/16/2002 | WO2002038753A1 Method of screening gene affecting pathological conditions or survival of animal infected with pathogen |
| 05/16/2002 | WO2002038744A2 Proteases |
| 05/16/2002 | WO2002038732A2 Human testis specific serine/threonine kinase |
| 05/16/2002 | WO2002038731A2 Method for measuring nucleotides |
| 05/16/2002 | WO2002038730A2 Novel human potassium channel beta subunit |
| 05/16/2002 | WO2002038729A2 GENE MONITORING AND GENE IDENTIFICATION USING cDNA ARRAYS |
| 05/16/2002 | WO2002038724A2 A method for the detection of viable microorganisms |
| 05/16/2002 | WO2002038608A2 Methods of screening for ltrpc2 modulators |
| 05/16/2002 | WO2002038607A2 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | WO2002038602A2 Secreted proteins |
| 05/16/2002 | WO2002038600A2 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 05/16/2002 | WO2002038596A1 Method of identifying antibacterial compounds |
| 05/16/2002 | WO2002038594A1 Novel therapeutic compositions for treating infection by lawsonia spp |
| 05/16/2002 | WO2002038589A2 Haplotypes of the cyp2d6 gene |
| 05/16/2002 | WO2002038540A2 Activity-dependent cysteine protease profiling reagent |
| 05/16/2002 | WO2002038173A1 Vaccine based on a cellular penetration factor from an apicomplexan parasite |
| 05/16/2002 | WO2002038108A2 Methods of treating disorders related to apoe |
| 05/16/2002 | WO2002038035A2 Methods for inhibiting pain |
| 05/16/2002 | WO2002038032A2 Methods and devices for collecting and processing mammary fluid |
| 05/16/2002 | WO2002037938A2 Method and device for selectively targeting cells within a three -dimensional specimen |
| 05/16/2002 | WO2002020003A3 Use of carp inhibitors for the treatment of heart diseases |
| 05/16/2002 | WO2002018413A3 Haplotypes of the scya2 gene |
| 05/16/2002 | WO2002009012A3 Accessibility correction factors for electronic models of cytochrome p450 metabolism |
| 05/16/2002 | WO2002002806A3 Method and nucleic acids for analysing the methylation of genes implicated in pharmacogenomics |
| 05/16/2002 | WO2001096594A3 Test system for determining the activity of cyclo-nucleotide-dependent protein kinases and vasp phosphatases |
| 05/16/2002 | WO2001096593A3 Novel motor proteins and methods for their use |
| 05/16/2002 | WO2001094629A8 Cancer gene determination and therapeutic screening using signature gene sets |
| 05/16/2002 | WO2001094614A3 Methods for monitoring enzyme activity |
| 05/16/2002 | WO2001092496A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/16/2002 | WO2001090313A3 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS |
| 05/16/2002 | WO2001088533A3 Lipid uptake assays |
| 05/16/2002 | WO2001087903A3 Haplotypes of the acaa1 gene |
| 05/16/2002 | WO2001086288A3 Early diagnosis of bladder tumor in urine samples |
| 05/16/2002 | WO2001086003A8 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human lung |
| 05/16/2002 | WO2001085913A3 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
| 05/16/2002 | WO2001083547A3 Anti-inflammatory compounds and uses thereof |
| 05/16/2002 | WO2001081622A8 Diagnosis of diseases associated with dna repair |
| 05/16/2002 | WO2001081599A3 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 05/16/2002 | WO2001080810A3 Chondroitin synthase gene and methods of making and using same |
| 05/16/2002 | WO2001079492A3 Lipid binding protein 3 |
| 05/16/2002 | WO2001077670A3 Homocysteine assay |
| 05/16/2002 | WO2001077126A3 Haplotypes of the hsd3b2 gene |
| 05/16/2002 | WO2001075142A3 Protein kinase assay |
| 05/16/2002 | WO2001074857A3 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 05/16/2002 | WO2001072978A3 Aryl propenal double bond reductase |
| 05/16/2002 | WO2001070953A3 Identification of modulators of the inteferon gamma signaling pathway and their use in restenosis treatment |
| 05/16/2002 | WO2001065461A3 Process for estimating random error in chemical and biological assays |
| 05/16/2002 | WO2001057237A3 Methods employing increased dye-fluorescence upon nitroreduction |
| 05/16/2002 | WO2001048184A3 Method for carrying out the parallel sequencing of a nucleic acid mixture on a surface |
| 05/16/2002 | WO2001047959A3 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 05/16/2002 | WO2001040521A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/16/2002 | WO2001034765A9 Methods and apparatus for the electronic, homogeneous assembly and fabrication of devices |
| 05/16/2002 | WO2001034636A9 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/16/2002 | WO2001032928A9 Methods of determining individual hypersensitivity to an agent |
| 05/16/2002 | WO2001032885A9 Human lipase |
| 05/16/2002 | WO2001032685A8 Gene expression directed by a super-psa promoter |
| 05/16/2002 | WO2001029255A3 Diagnostic test for cephalic pain |
| 05/16/2002 | WO2001029235A3 Tms1 compositions and methods of use |
| 05/16/2002 | WO2001027331A3 Detection of nucleic acid heteroduplex molecules by anion-exchange chromatography |
| 05/16/2002 | WO2001025480A3 Dna sequencing method |
| 05/16/2002 | US20020059653 Modulating protein complex formation in cells; obtain sample tissue, incubate with acetylcholine esterase, expose to modulator, monitor sample for complex formation |
| 05/16/2002 | US20020059652 Detecting modulators of liver cell propagation, cell differentiation and lymphocyte activity; obtain modulator, incubate with indicator, mix with culture monitor culture for adjustment in activity |
| 05/16/2002 | US20020058887 Cytological evaluation of breast duct epithelial cells retrieved by ductal lavage |
| 05/16/2002 | US20020058638 Decreasing blood glucose levels, inhibiting PEPCK expression, decreasing blood insulin levels, decreasing insulin resistance, increasing insulin sensitivity, decreasing blood triglyceride levels or decreasing blood cholesterol levels |
| 05/16/2002 | US20020058636 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 05/16/2002 | US20020058613 Modulating the expression or bioactivity of a bcl family member in a neural cell such that axonal growth occurs. |
| 05/16/2002 | US20020058610 DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques; inhibiting such polypeptide for preventing and/or treating neoplasia; diagnostic assays |
| 05/16/2002 | US20020058329 Multiple-site reaction device and method |
| 05/16/2002 | US20020058327 Materials and methods for the enhancement of effective root nodulation in legumes |
| 05/16/2002 | US20020058321 Method of determining the activity of 1-deoxy-D-xylulose-5-phosphate reductoisomerase and 1-deoxy-D-xylulose-5-phosphate synthase |
| 05/16/2002 | US20020058306 Nucleotide sequences coding preferential protein for use in the diagnosis and treatment of brain and psychological disorders |
| 05/16/2002 | US20020058301 Compound for use in the diagnosis and treatment of urogential and kidney disorders |
| 05/16/2002 | US20020058299 Mycologic genera specific selective agar and method of manufacture |
| 05/16/2002 | US20020058298 Compositions and methods for detecting target microorganisms in a sample |
| 05/16/2002 | US20020058297 Microorganism for use as model in screening microbiocides and bactericides |
| 05/16/2002 | US20020058295 Method of screening candidate compounds for susceptibility to oxidative metabolism |
| 05/16/2002 | US20020058290 Stable genetically engineered muscle cell; for use in the generation of modulators for treatment of cancer, metabolic defects, cachexia and aging defects |
| 05/16/2002 | US20020058282 Apparatus for analysis of a nucleic acid amplification reaction |
| 05/16/2002 | US20020058281 Performing polymerase chain reactions in vessel; obtain nucleotide equences, incubate with primers, denature, accumulate nucleotide sequences, recover nucleotide sequences |
| 05/16/2002 | US20020058280 Metal chelate containing compositions for use in chemiluminescent assays |
| 05/16/2002 | US20020058278 Screening for nucleotide sequences in sample; obtain sample, incubate with peptide nucleic acid probes, expose to antibodies, detect bound triplex structure, presence of bound triplex indicates presence of preferential nucleotide |
| 05/16/2002 | US20020058275 Adjustment of defective fitting nucleotide sequences; obtain nucleotide sequence samples, incubate dimer binding protein, monitor sample for bound complexes |
| 05/16/2002 | US20020058273 Method and system for rapid biomolecular recognition of amino acids and protein sequencing |
| 05/16/2002 | US20020058272 Luminescent marker; for use in the detection of preferential nucleotide sequences |
| 05/16/2002 | US20020058271 Screen for the pesence of preferential nucleotide sequences; obtain nucleotide sequences, incubate with primer, expose to polymerase, reduce backgroud noise, measure the amount of nucleotide sequences, screen for presence of target |
| 05/16/2002 | US20020058270 Methods and compositions for transcription-based nucleic acid amplification |
| 05/16/2002 | US20020058267 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's disease |
| 05/16/2002 | US20020058266 Polypeptide for use in preventing plasmodium infection |
| 05/16/2002 | US20020058265 Analyzing preferential genetic mapping positions; obtain nucleotide sequences, incubate with primers, amplify nucleotide sequences, determine the size of the amplified nucleotide sequences |
| 05/16/2002 | US20020058264 Human regulatory molecules |
| 05/16/2002 | US20020058263 Generalized target-binding e-tag probe compositions |
| 05/16/2002 | US20020058262 Method for determining the efficiency of nucleic acid amplifications |
| 05/16/2002 | US20020058261 Recovering data from microarrays; obtain nucleotide sequence sample, incubate with probes, compare binding of probes, determine nucleotide sequences |